generic
-
Global generic drug markets will grow to US$221 billion by 2016
Driven by the need to control costs, the use of generic drugs has grown considerably in recent years, even in markets where traditionally they have not been favored.
generic | 23 May 2012
-
US Supreme Court clears way for generic patent challenges
After the ruling, generic manufacturers will now be able to challenge the content of patent descriptions and, if successful, ultimately force approval of the ANDA. Writing for the Court in a unanimous decision, Justice Elena Kagan chastised the FDA for using ambiguous or opaque guidelines and forms that lend to the confusion surrounding patent decisions.
generic | 18 May 2012
-
Generic drug manufacturers forge alliances in face of tough economic climate
The generic drugs sector’s role as the provider of affordable drugs has widely benefitted public and private health payers keen to control costs. But in the current economic climate, downward pressure on prices is impacting the generic sector, with increases in acquisition and strategic partnering now firmly part of the competitive landscape.
generic | 28 February 2012
-
India generics companies lead pharmaceutical innovation in Asia Pacific
Thomson Reuters Asia Pacific R&D Factbook details significant increases in innovation investment and development of novel drug pipelines.
generic | 30 September 2011
-
FUJIFILM, Dr Reddy's establish exclusive joint venture on generic drugs in Japan
FUJIFILM Corporation President and CEO, Shigetaka Komori and Dr Reddy's Laboratories Ltd Vice-Chairman and CEO, G V Prasad signed a memorandum of understanding to enter into an exclusive partnership in the generic drugs business for the Japanese mark…
generic | 29 July 2011
-
Merck, Sun Pharma establish joint venture on generics
Joint venture to apply proprietary technologies to develop medicines designed to enhance convenience and improve compliance
generic | 12 April 2011
-
Watson announces approval of generic alternative for the treatment of iron deficiency anemia
Watson Pharmaceuticals Inc announced that it is initiating launch activities of Nulecit (sodium ferric gluconate complex in sucrose injection), following FDA approval of GeneraMedix Inc's abbreviated new drug application (ANDA). Nulecit is said to be…
generic | 01 April 2011
-
Watson Laboratories launches generic Famvir
Watson Pharmaceuticals Inc confirmed that its subsidiary, Watson Laboratories Inc has launched Famciclovir tablets, 125 mg, 250 mg and 500 mg, the generic version of Novartis' Famvir following approval of its Abbreviated New Drug Application (ANDA) b…
generic | 21 March 2011
-
Research and Markets: Japanese generic market with forecast to 2013
Research and Markets has announced the addition of the "Japanese Generic Market Forecast to 2013" report to their offering. Generic drugs are produced and distributed without patent protection and marketed after the expiry date of patent or other…
generic | 16 March 2011
-
Generics pick up steam in Southeast Asia
The Southeast Asian generics drug market is slowly gaining more attention from both patients and governments. In most of the markets, there are changes in consumption patterns; however, the focus on primary care persists. In developed countries such …
generic | 01 March 2011
